B Khasanov Alisher

Title: The Innovations of B Khasanov Alisher

B Khasanov Alisher is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of targeted cancer therapies. His work focuses on creating innovative solutions that can improve patient outcomes in oncology.

Latest Patents

Alisher holds a patent for an "Anti-HER2 antibody-drug conjugate and application thereof." This invention involves an anti-human epidermal growth factor receptor 2 (anti-HER2) antibody-drug conjugate or a pharmaceutically acceptable salt thereof. The application of this anti-HER2 antibody-drug conjugate is aimed at preparing an antitumor pharmaceutical product. This patent highlights his commitment to advancing cancer treatment options.

Career Highlights

Alisher is currently employed at Hangzhou Adcoris Biopharma Co., Ltd., where he continues to innovate in the biopharmaceutical sector. His work at this company allows him to collaborate with other talented professionals in the field. He has been instrumental in driving research and development initiatives that focus on creating effective therapies for cancer patients.

Collaborations

Some of his notable coworkers include Zhenwei Miao and Tong Zhu. Their collaboration fosters a dynamic environment for innovation and research, contributing to the overall success of their projects.

Conclusion

B Khasanov Alisher is a prominent figure in the biopharmaceutical industry, with a focus on developing innovative cancer therapies. His patent for the anti-HER2 antibody-drug conjugate exemplifies his dedication to improving treatment options for patients. Through his work at Hangzhou Adcoris Biopharma Co., Ltd., he continues to make strides in the field of oncology.